Literature DB >> 19479632

Ascites: pathogenesis and therapeutic principles.

Søren Møller1, Jens H Henriksen, Flemming Bendtsen.   

Abstract

Ascites is a classic complication of advanced cirrhosis and it often marks the first sign of hepatic decompensation. Ascites occurs in more than 50% of patients with cirrhosis, worsens the course of the disease, and reduces survival substantially. Portal hypertension, splanchnic vasodilatation, liver insufficiency, and cardiovascular dysfunction are major pathophysiological hallmarks. Modern treatment of ascites is based on this recognition and includes modest salt restriction and stepwise diuretic therapy with spironolactone and loop-diuretics. Tense and refractory ascites should be treated with large volume paracentesis followed by plasma volume expansion or transjugular intrahepatic portosystemic shunt. Ascites complicated by spontaneous bacterial peritonitis requires adequate treatment with antibiotics. New potential treatment strategies include the use of vasopressin V(2)-receptor antagonists and vasoconstrictors. Since formation of ascites is associated with a poor prognosis, and treatment of fluid retention does not substantially improve survival, such patients should always be considered for liver transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19479632     DOI: 10.1080/00365520902912555

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  5 in total

1.  Automated analysis for differentiating leukocytes in body fluids using the software "biological liquid application" on ADVIA2120/2120i hematology analyzer.

Authors:  Alessandra Falda; Paolo Doretto
Journal:  J Clin Lab Anal       Date:  2018-05-25       Impact factor: 2.352

Review 2.  Invasive and non-invasive techniques for detecting portal hypertension and predicting variceal bleeding in cirrhosis: a review.

Authors:  Enrico Maria Zardi; Francesco Maria Di Matteo; Claudio Maurizio Pacella; Arun J Sanyal
Journal:  Ann Med       Date:  2013-12-16       Impact factor: 4.709

Review 3.  Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications.

Authors:  Csaba Matyas; György Haskó; Lucas Liaudet; Eszter Trojnar; Pal Pacher
Journal:  Nat Rev Cardiol       Date:  2020-09-30       Impact factor: 32.419

4.  Quantitative modeling of the physiology of ascites in portal hypertension.

Authors:  David G Levitt; Michael D Levitt
Journal:  BMC Gastroenterol       Date:  2012-03-27       Impact factor: 3.067

5.  Preserved renal function during long-term follow-up in children with chronic liver disease.

Authors:  Ulla B Berg; Henrike Häbel; Antal Németh
Journal:  Acta Paediatr       Date:  2022-03-05       Impact factor: 4.056

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.